Is a complete DTIL research report available?

No complete published report is available for Precision BioSciences, Inc. (DTIL) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Precision BioSciences, Inc. (DTIL)

NASDAQ: DTIL · USD

$7.29

-0.04 (-0.6%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first DTIL analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	188.1M
Revenue (ttm)	45.1M
Net income (ttm)	-43.6M
EPS (ttm)	-$2.62
Shares out	25.8M
Volume	192,245
Beta	1.25
Price target	$29.6	+306.0%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 45.1M
Net income (ttm): -43.6M
EPS (ttm): -$2.62
Market cap: 188.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All DTIL indicators

Market & fundamental data

Available fields

218

Groups with data

Currency

USD

Showing 218 of 218 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001357874
Company name	Precision BioSciences, Inc.
Country	United States
Country code	US
Cusip	74019P207
Employees	66
Employees Change	-41%
Employees Change Percent	-38.32
Enterprise value	$115.4M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2019-03-28
Isin	US74019P2074
Last refreshed	2026-07-25
Market cap	$188.1M
Market cap category	Micro-Cap
Price	$7.29
Price currency	USD
Rev Per Employee	682,924.24x
Sector	Healthcare
Sector PE	44.87
Sector PE Fwd	23.76
Sic	2836
Symbol	DTIL
Website	https://precisionbiosciences.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-23.18%
EV Sales Forward	11.31x
EV/EBIT	0.89x
EV/EBITDA	0.88x
EV/Sales	2.56x
FCF yield	-31.24%
P/B ratio	2.49x
P/S ratio	4.17x
PS Forward	18.44x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	286.77%
EBITDA Margin	289.82%
Gross margin	100%
Gross Profit	$45.1M
Gross Profit Growth	-11.87%
Gross Profit Growth Q	37,272.41%
Gross Profit Growth3 Y	13.83%
Gross Profit Growth5 Y	6.03%
Net Income	$-43.6M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	-98.7%
Profit Margin	-96.73%
Profit Per Employee	$-660,606
ROA	-18.22
Roa5y	-15.63
ROCE	94.95
ROE	-70.93
Roe5y	-58.45
ROIC	-26.62

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	47.61%
Cagr3y	-27.62%
Cagr5y	-52.69%
EPS Growth Quarters	3
EPS Growth Years	0
Revenue Growth	-11.87x
Revenue Growth Q	37,272.41x
Revenue Growth Quarters	2x
Revenue Growth Years	0x
Revenue Growth3 Y	13.83x
Revenue Growth5 Y	6.03x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.34
Assets	$143.9M
Cash	$101.2M
Current Assets	$108.7M
Current Liabilities	$7.8M
Debt	$28.5M
Debt EBITDA	$0.22
Debt Equity	$0.37
Equity	$76.1M
Interest Coverage	93.73
Liabilities	$67.8M
Long Term Assets	$35.2M
Long Term Liabilities	$60M
Net Cash	$72.7M
Net Cash By Market Cap	$38.66
Net Cash Growth	53.17%
Net Debt EBITDA	$-0.56
Net Debt Equity	$-0.96
Tangible Book Value	$75M
Tangible Book Value Per Share	$2.91
WACC	10.17

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	14.02
Net Working Capital	$1.3M
Quick ratio	13.56
Working Capital	$100.9M
Working Capital Turnover	$0.53

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-111.15%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	47.57%
200-day SMA	5.99
3Y total return	-62.09%
50-day SMA	7.38
50-day SMA vs 200-day SMA	50over200
5Y total return	-97.63%
All Time High	710.1
All Time High Change	-98.97%
All Time High Date	2019-12-09
All Time Low	3.53
All Time Low Change	106.52%
All Time Low Date	2026-02-05
ATR	0.57
Beta	1.25
Beta1y	1.64
Beta2y	0.6
Ch YTD	75.24
High	7.68
High52	9.62
High52 Date	2026-07-07
High52ch	-24.22%
Low	7.13
Low52	3.53
Low52 Date	2026-02-05
Low52ch	106.52%
Ma50ch	-1.25%
Price vs 200-day SMA	21.62%
RSI	43.06
RSI Monthly	39.71
RSI Weekly	55.28
Sharpe ratio	0.85x
Sortino ratio	1.38
Total Return	-111.15%
Tr YTD	75.24
Tr1m	4.89%
Tr1w	-7.37%
Tr3m	-0.27%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	3
Analyst Price Target Top	$36.33
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.68
Earnings Revenue Estimate	1,780,000x
Earnings Revenue Estimate Growth	9,788.89x
Operating Income	$-39.1M
Operating margin	-86.77
Price target	$29.6
Price Target Change	$306
Price Target Change Top	$398

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	20,005,231%
Float Percent	77.53%
Shares Insiders	4.56%
Shares Institutions	52.45%
Shares Out	25,802,247
Shares Qo Q	28.49%
Shares Yo Y	111.15%
Short Float	11.48%
Short Ratio	4.54
Short Shares	8.9

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-67.7M
Average Volume	670,275.85x
Bv Per Share	2.95
CAPEX	$-39,000
Ch1m	4.89
Ch1w	-7.37
Ch1y	47.57
Ch3m	-0.27
Ch3y	-62.09
Ch5y	-97.63
Ch6m	73.57
Change	-0.55%
Change From Open	-1.75
Close	7.33
Days Gap	1.23
Depreciation Amortization	1,372,000
Dollar Volume	1,401,466.1
Earnings Date	2026-07-31
Earnings Time	bmo
EBIT	$129.3M
EBITDA	$130.6M
EPS	$-2.62
F Score	2
FCF	$-58.8M
FCF EV Yield	-50.93x
FCF Per Share	$-2.28
Financing CF	85,220,000
Fiscal Year End	December
Founded	2,006
Investing CF	-434,000
Ipr	-54.44
Iprfo	-98.65
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Date	2024-02-14
Last Split Type	Reverse
Last10k Filing Date	2026-03-12
Ma150	6.01
Ma150ch	21.32%
Ma20	8.15
Ma20ch	-10.51%
Net CF	26,058,000
Next Earnings Date	2026-08-06
Open	7.42
Optionable	Yes
Position In Range	29.09
Post Close	7.29
Postmarket Change Percent	-0.14
Postmarket Price	$7.28
Ppne	6,647,000
Price Date	2026-07-24
Price EBITDA	$1.44
Ptbv Ratio	2.51
Relative Volume	0.29x
Revenue	45,073,000x
SBC By Revenue	19.77x
Share Based Comp	8,913,000
Tr6m	73.57%
Us State	North Carolina
Volume	192,245
Z Score	-4.35

Precision BioSciences, Inc. (DTIL)

Coverage state: Market snapshot only — no published research

Generate the first DTIL analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · DTIL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All DTIL indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on DTIL

Frequently asked questions